James West

9.2k total citations
172 papers, 6.4k citations indexed

About

James West is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, James West has authored 172 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Pulmonary and Respiratory Medicine, 50 papers in Molecular Biology and 36 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in James West's work include Pulmonary Hypertension Research and Treatments (108 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers) and Cardiovascular Function and Risk Factors (17 papers). James West is often cited by papers focused on Pulmonary Hypertension Research and Treatments (108 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers) and Cardiovascular Function and Risk Factors (17 papers). James West collaborates with scholars based in United States, Japan and United Kingdom. James West's co-authors include Anna R. Hemnes, Eric D. Austin, James E. Loyd, Joshua P. Fessel, Megha Talati, Rizwan Hamid, David M. Rodman, Julie W. Harral, Kirk B. Lane and John A. Phillips and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and Circulation.

In The Last Decade

James West

169 papers receiving 6.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James West United States 49 4.1k 2.2k 1.7k 696 655 172 6.4k
Andrea Olschewski Austria 44 3.5k 0.9× 2.0k 0.9× 1.6k 1.0× 700 1.0× 768 1.2× 155 6.2k
Soni Savai Pullamsetti Germany 46 4.3k 1.1× 2.9k 1.3× 1.7k 1.0× 1.3k 1.9× 671 1.0× 132 7.2k
Maria G. Frid United States 44 3.6k 0.9× 3.0k 1.4× 1.3k 0.8× 1.7k 2.4× 1.1k 1.6× 79 7.6k
Robert Voswinckel Germany 39 3.8k 0.9× 1.6k 0.7× 2.1k 1.3× 354 0.5× 1.1k 1.6× 99 5.8k
Allan Lawrie United Kingdom 40 2.2k 0.6× 1.3k 0.6× 1.1k 0.7× 549 0.8× 382 0.6× 106 4.4k
Grażyna Kwapiszewska Austria 38 2.7k 0.7× 1.4k 0.6× 836 0.5× 529 0.8× 528 0.8× 126 4.3k
You‐Yang Zhao United States 37 1.5k 0.4× 2.6k 1.2× 1.4k 0.8× 675 1.0× 572 0.9× 82 5.7k
Karen A. Fagan United States 30 3.0k 0.7× 1.1k 0.5× 1.2k 0.7× 458 0.7× 459 0.7× 46 4.3k
J. Usha Raj United States 40 3.1k 0.8× 1.8k 0.8× 976 0.6× 981 1.4× 856 1.3× 181 5.3k
Jeffrey A. Jones United States 39 1.4k 0.4× 1.3k 0.6× 782 0.5× 411 0.6× 656 1.0× 130 4.4k

Countries citing papers authored by James West

Since Specialization
Citations

This map shows the geographic impact of James West's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James West with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James West more than expected).

Fields of papers citing papers by James West

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James West. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James West. The network helps show where James West may publish in the future.

Co-authorship network of co-authors of James West

This figure shows the co-authorship network connecting the top 25 collaborators of James West. A scholar is included among the top collaborators of James West based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James West. James West is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gutor, Sergey, David S. Nichols, Wei Han, et al.. (2024). Repetitive sulfur dioxide exposure in mice models post-deployment respiratory syndrome. American Journal of Physiology-Lung Cellular and Molecular Physiology. 326(5). L539–L550. 4 indexed citations
2.
Hemnes, Anna R., Niki Fortune, Katherine Simon, et al.. (2024). A multimodal approach identifies lactate as a central feature of right ventricular failure that is detectable in human plasma. Frontiers in Medicine. 11. 1387195–1387195.
3.
Talati, Megha, Evan L. Brittain, Vineet Agrawal, et al.. (2023). A potential adverse role for leptin and cardiac leptin receptor in the right ventricle in pulmonary arterial hypertension: effect of metformin is BMPR2 mutation-specific. Frontiers in Medicine. 10. 1276422–1276422. 1 indexed citations
4.
Riley, Lance A., et al.. (2022). Loss of talin in cardiac fibroblasts results in augmented ventricular cardiomyocyte hypertrophy in response to pressure overload. American Journal of Physiology-Heart and Circulatory Physiology. 322(5). H857–H866. 8 indexed citations
5.
West, James, Eric D. Austin, Yan Ling, et al.. (2021). KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models. International Journal of Molecular Sciences. 22(9). 5014–5014. 11 indexed citations
6.
Torshizi, Mohammad Amir Karimi, et al.. (2021). Impacts of caffeine on resistant chicken's performance and cardiovascular gene expression. Journal of Animal Physiology and Animal Nutrition. 106(3). 566–574. 1 indexed citations
7.
Bryant, Andrew J., Borna Mehrad, Todd M. Brusko, James West, & Lyle L. Moldawer. (2018). Myeloid-Derived Suppressor Cells and Pulmonary Hypertension. International Journal of Molecular Sciences. 19(8). 2277–2277. 7 indexed citations
8.
Suzuki, Toshio, Erica J. Carrier, Megha Talati, et al.. (2017). Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 314(1). L118–L126. 78 indexed citations
9.
Pickworth, Josephine, Alexander Rothman, James Iremonger, et al.. (2017). Differential IL‐1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling. Pulmonary Circulation. 7(4). 768–776. 20 indexed citations
10.
Talati, Megha, Evan L. Brittain, Joshua P. Fessel, et al.. (2016). Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle. American Journal of Respiratory and Critical Care Medicine. 194(6). 719–728. 80 indexed citations
11.
Austin, Eric D., James West, James E. Loyd, & Anna R. Hemnes. (2016). T ranslational A dvances   in   the F ield   of P ulmonary H ypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing. American Journal of Respiratory and Critical Care Medicine. 195(1). 23–31. 28 indexed citations
12.
Lu, Yan, Megha Talati, Santhi Gladson, et al.. (2015). Bone Marrow-derived Cells Contribute to Pathogenesis of Pulmonary Arterial Hypertension.. American Journal of Respiratory and Critical Care Medicine. 2 indexed citations
13.
Hemnes, Anna R., Aaron W. Trammell, Stephen L. Archer, et al.. (2014). Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension. Circulation. 131(4). 401–409. 59 indexed citations
14.
Fessel, Joshua P., Charles R. Flynn, Linda Robinson, et al.. (2013). Hyperoxia Synergizes with Mutant Bone Morphogenic Protein Receptor 2 to Cause Metabolic Stress, Oxidant Injury, and Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 49(5). 778–787. 34 indexed citations
15.
Austin, Eric D., Lijiang Ma, Charles A. LeDuc, et al.. (2012). Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension. Circulation Cardiovascular Genetics. 5(3). 336–343. 267 indexed citations
16.
Flynn, Charles R., Siyuan Zheng, Yan Ling, et al.. (2012). Connectivity Map Analysis of Nonsense-Mediated Decay–Positive BMPR2 -Related Hereditary Pulmonary Arterial Hypertension Provides Insights into Disease Penetrance. American Journal of Respiratory Cell and Molecular Biology. 47(1). 20–27. 17 indexed citations
17.
Larkin, Emma K., John H. Newman, Eric D. Austin, et al.. (2012). Longitudinal Analysis Casts Doubt on the Presence of Genetic Anticipation in Heritable Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 186(9). 892–896. 148 indexed citations
18.
Dickinson, Hayley, et al.. (2010). MATERNAL CREATINE PRE-TREATMENT PROTECTS THE NEWBORN BRAIN AND DIAPHRAGM FROM HYPOXIC INJURY. Pediatric Research. 68(2). 175–175. 2 indexed citations
19.
Saavedra, Milene T., Grant Hughes, Linda Sanders, et al.. (2008). Circulating RNA Transcripts Identify Therapeutic Response in Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine. 178(9). 929–938. 15 indexed citations
20.
Lu, Xiaojun, Jack L. Arbiser, James West, et al.. (2004). Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Can Induce Apoptosis in Subsets of Premalignant Cells. American Journal Of Pathology. 165(5). 1613–1620. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026